Balancing Innovation and Ethics: Preventive Medicine, Big Data, and Cybersecurity in Healthcare
By Jonathan Brière, M.Sc., Bioinformatician, Molecular Genetics, Viral Vector Production and Gene Therapy Specialist at the National Research Council of Canada (NRC)
A Technological Revolution Transforming Healthcare
Healthcare is on the brink of transformation—poised to revolutionize patient care or risk eroding public trust through data breaches. Since the completion of the Human Genome Project in 2003, breakthroughs in omics technologies—genomics, proteomics, metabolomics, and beyond—have redefined how we prevent, diagnose, and treat disease. Once confined to research labs, personalized and preventive medicine is now a tangible reality.
Yet, with this progress comes responsibility. To fully harness these innovations, we must ensure they empower individuals, safeguard privacy, and guarantee equitable access to care. Innovation must be driven by unwavering ethical responsibility—balancing technological advancement with human-centered care.
The Rapid Growth of Preventive Medicine
Preventive healthcare has become indispensable in modern medicine. The global personalized medicine market soared to $140 billion USD in 2022, more than doubling from $60 billion in 20171, driven by breakthroughs in genetic sequencing, biomarker discovery, and tailored therapies. Tailored nutrition, wellness initiatives, and precision therapies are fueling this market expansion.
Wearable Health Monitoring Devices empower individuals to monitor health in real time2,3.
Many health trends, such as fad diets, lack scientific evidence. Multi-omics technologies and biosensors provide evidence-based, personalized insights that outperform fleeting trends, but unlocking their full potential requires tackling critical challenges in data management, data integration, ethics, and privacy protection4.
Personalized and preventive medicine is transforming healthcare—offering targeted treatments, reducing costs, and driving economic growth. Yet, without responsible management, big data overload, cybersecurity threats, and privacy breaches could erode individual rights and widen healthcare disparities.
Big Data in Healthcare: Tackling the Omics Data Explosion
The rapid expansion of multi-omics technologies has led to an unprecedented surge in data generation. Sequencing a single genome with PacBio’s long-read technology produces between 0.5 and 1.5 TB of data5, and when combined with other omics layers, this can exceed 5 TB per individual. By 2025, genomics data is projected to surpass the data output of entire industries like astronomy, YouTube, and X6.
This data explosion strains existing IT infrastructures. Without significant investments in high-performance computing, advanced data compression, and secure storage, healthcare systems risk being overwhelmed. Industry leaders like Illumina, PacBio and Oxford Nanopore have improved data processing with GPU optimization and cutting-edge compression tools7-10. To stay ahead, healthcare organizations should partner with independent bioinformatics firms and open-source platforms to develop secure, scalable data solutions.
However, increased reliance on cloud computing heightens cybersecurity risks. Recent cyberattacks on healthcare systems have revealed major vulnerabilities, underscoring the need for robust, proactive security frameworks11-13. Immediate cross-sector collaboration is essential to implement standardized data security protocols, strengthen infrastructure, and mitigate rising cyber threats4.
Integrating Omics Technologies: Bridging Disciplinary Gaps
Integrating genetic, microbiome, and biomarker data is crucial to realizing precision medicine’s full potential. Yet, fragmented analytical tools, isolated data silos, and the absence of industry wide standards continue to obstruct the translation of these complex datasets into targeted, personalized therapies for chronic and multifactorial diseases. Molla and Bitew (2023)14
emphasize that despite the promise of multi-omics technologies in enabling precise therapeutic strategies, challenges like data complexity, high costs, and privacy concerns significantly slow their adoption in clinical practice.
Overcoming these barriers requires moving beyond competitive research models by establishing dedicated, cross-disciplinary task forces. Regular collaborative meetings between clinicians, bioinformaticians, statisticians, data scientists, cybersecurity experts, and policymakers can standardize data integration workflows and improve the interpretation of complex datasets. Like the UK Biobank, government-supported consortia could incentivize data sharing and foster integrated research pipelines4,14,15.
However, integrating sensitive health data across disciplines also increases cybersecurity risks. To address this, collaboration must include cybersecurity experts to design robust security frameworks that evolve alongside data-sharing initiatives. This integrated approach can dismantle data silos, accelerate discoveries, and deliver safer, more effective, personalized healthcare solutions.
Data Privacy: Navigating Ethical and Technological Risks
The rise of direct-to-consumer genetic testing (DTC-GT) has exposed critical data security vulnerabilities. The 2023 data breach at 23andMe compromised sensitive genetic data from more than 14,000 customers, prompting international investigations and raising concerns about biotech data protection practices16-18. Similarly, the 2021 ransomware attack on Ireland’s Health Service Executive (HSE) crippled healthcare operations for months, resulting in over $100 million EUR in damages12.
These breaches underscore the severe consequences of inadequate data safeguards. Weak data protections risk discrimination by insurers, employers, and governments. The potential commercialization of genetic data during corporate mergers raises additional ethical concerns19. To encourage widespread data sharing without compromising privacy, legal frameworks must mirror protections like the UK’s Genomic Protection Law, which prohibits insurers from using genetic data in underwriting decisions. International coalitions should standardize data privacy
laws, mirroring the UK’s genomic data protections. The global alignment will build trust and support large-scale health data sharing15,20,21.
Protecting health data is not just a technical requirement—it is a human rights imperative.
Building Resilient Data Protection Frameworks
Healthcare systems must adopt comprehensive cybersecurity strategies aligned with global standards, including:
• ISO/IEC 27001 certification to enforce rigorous data security protocols.
• Multi-factor authentication (MFA) using biometrics and dynamic passwords for secure access.
• Dedicated cybersecurity teams for continuous threat monitoring and rapid incident response.
• User education programs to promote responsible data sharing and cybersecurity awareness.
However, a truly innovative solution lies in integrating blockchain technology with zero-trust security models22. Blockchain offers decentralized data management, immutable audit trails, and enhanced data provenance—making it ideal for securing sensitive health records. For example, Estonia’s eHealth system uses blockchain to secure over 1 million patient records, providing real-time audit trails and preventing data tampering23. Healthcare providers should launch small-scale blockchain pilot programs to secure patient data. Partnering with firms like Guardtime can streamline integration. These trials will identify risks and optimize scalability.
Still, technology alone isn’t enough. Ethical governance, transparent policies, and strict regulatory compliance are crucial to maintaining public trust and protecting sensitive health data.
Balancing Innovation and Security: Delivering Measurable Impact
Despite the challenges of managing vast datasets and safeguarding sensitive health information, personalized and preventive medicine holds transformative potential. Chronic diseases like diabetes and cardiovascular conditions drive 86% of U.S. healthcare costs24-28. Early detection and preventive care can drastically reduce hospitalizations and healthcare spending. For instance, early diabetes detection alone could save the U.S. healthcare system $327 billion annually27.
Preventive care not only lowers direct healthcare costs but also strengthens economies. In Canada, chronic diseases consume 40% of public healthcare budgets. Prioritizing preventive care could redirect billions toward research and development, fueling medical innovation and improving patient outcomes24.
Closing health equity gaps could inject $2.8 trillion into the U.S. economy by 2040 (Deloitte)29, while globally, better health outcomes could raise GDP by an extraordinary $12 trillion (McKinsey & Company)30.
Conclusion: Driving Innovation Responsibly
Personalized and preventive medicine is transforming healthcare—offering targeted treatments, reducing costs, and driving economic growth. Yet, without responsible management, big data overload, cybersecurity threats, and privacy breaches could erode individual rights and widen healthcare disparities.
To truly benefit society, innovation must prioritize people. This requires enforcing rigorous data security, robust regulations, and adaptive ethical governance to protect both scientific progress and personal freedoms. Equally important is fostering cross-disciplinary collaboration among clinicians, bioinformaticians, data scientists, and policymakers to break down data silos and enable seamless integration of multi-omics data for more effective, personalized healthcare solutions.
By acting now, we can build an innovative, secure, equitable, and resilient healthcare system for future generations.
References:
1 Mikulic, M. Personalized medicine – Statistics & Facts, <https://www.statista.com/topics/4345/personalized-medicine/#topicOverview> (2024). 2 Kalinin, K. Wearable Technology in Healthcare: The Future of Medical Devices, <https://topflightapps.com/ideas/wearabletechnology-in-healthcare/> (2024).
3 Laricchia, F. Fitbit – statistics & facts, <https://www.statista.com/topics/2595/fitbit/#topicOverview> (2024).
4 Athieniti, E. & Spyrou, G. M. A guide to multi-omics data collection and integration for translational medicine. Computational and Structural Biotechnology Journal 21, 134-149, doi:https://doi.org/10.1016/j.csbj.2022.11.050 (2023).
5 PacBio. Sequel® II and IIe Systems: Data Files (v10.1) (PacBio, 2021).
6 Stephens, Z. D. et al. Big Data: Astronomical or Genomical? PLoS Biol 13, e1002195, doi:10.1371/journal.pbio.1002195 (2015).
7 Chen, M. Scaling long-read sequencing throughput and accessibility with deep learning and NVIDIA, <https://www.pacb.com/blog/scaling-long-read-sequencing-throughput-and accessibility-with-deep-learning-and-nvidia/> (2023).
8 How much storage space is required for PromethION sequencing data?, <https://nanoporetech.com/support/devices/PromethION-24-and-48/how-much-storage space-is-required-for-promethion-sequencing-data> (2024).
9 Jayasooriya, K. et al. A new compression strategy to reduce the size of nanopore sequencing data. bioRxiv, 2024.2010.2002.616377, doi:10.1101/2024.10.02.616377 (2024).
10 Vlad-Mihai Sima & Boer, T. d. Data solution empowering population genomics research, <https://www.illumina.com/science/genomics-research/articles/data-solution-empowering population-genomics-research.html> (2021).
11 Mishra, V. Cyberattacks on healthcare: A global threat that can’t be ignored, <https://news.un.org/en/story/2024/11/1156751> (2024).
12 PROGRAM, H. C. (ed OFFICE OF INFORMATION SECURITY) (2022).
13 Stritch;, b. M. M., Winterburn;, M. & Houghton, F. The Conti Ransomware Attack on Healthcare in Ireland: Exploring the impacts of a Cybersecurity Breach from a Nursing Perspective. Canadian Journal of Nursing Informatics 16 (2021).
14 Molla, G. & Bitew, M. Revolutionizing Personalized Medicine: Synergy with Multi-Omics Data Generation, Main Hurdles, and Future Perspectives. Biomedicines 12,
doi:10.3390/biomedicines12122750 (2024).
15 Sudlow, C. et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLOS Medicine 12, e1001779, doi:10.1371/journal.pmed.1001779 (2015).
16 Privacy authorities for Canada and the United Kingdom launch joint investigation into 23andMe data breach, <https://www.priv.gc.ca/en/opc-news/news-and announcements/2024/an_240610b/> (2024).
17 23 and Me might be sold. What happens to the genetic data it owns?, <https://advisory.com/daily-briefing/2024/10/22/23-and-me> (2024).
18 Daniel, L. 23andMe To Pay Up To $10,000 To Data Breach Victims—Are You Eligible?, <https://www.forbes.com/sites/larsdaniel/2024/10/15/23andme-to-pay-up-to-10000-to-data breach-victims-are-you-eligible/> (2024).
19 Panacer, K. S. Ethical Issues Associated With Direct-to-Consumer Genetic Testing. Cureus 15, e39918, doi:10.7759/cureus.39918 (2023).
20 ABI. Code on Genetic Testing and Insurance, <https://www.abi.org.uk/data-and-resources/tools and-resources/genetics/code-on-genetic-testing-and insurance/#:~:text=The%20Code%2C%20published%20in%20October,how%20insurers%20use% 20genetic%20information.>
21 Rodriguez-Rincon, D. et al. Assessing the Impact of Developments in Genetic Testing on Insurers’ Risk Exposure. Rand Health Q 9, 5 (2022).
22 Kuo, T. T., Kim, H. E. & Ohno-Machado, L. Blockchain distributed ledger technologies for biomedical and health care applications. J Am Med Inform Assoc 24, 1211-1220, doi:10.1093/jamia/ocx068 (2017).
23 Tiik, M. The Road to eHealth in Estonia: Lessons Learned and Future Opportunities and Challenges. European Journal of Public Health 31, doi:10.1093/eurpub/ckab164.431 (2021).
24 Canada, P. H. A. o. Vol. 37 (ed Public Health Agency of Canada) (2017).
25 Drinan, K. How to Prevent Heart Disease: 8 Simple Steps,<https://www.uchicagomedicine.org/forefront/heart-and-vascular-articles/heart-month-3- steps-to-a-healthier-heart-right-now> (2023).
26 Gunja;, M. Z., Gumas;, E. D. & II, R. D. W. U.S. Health Care from a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes, <https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care global-perspective-2022> (2023).
27 Parker, E. D. et al. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care 47, 26-43, doi:10.2337/dci23-0085 (2024).
28 Tarride, J. E. et al. A review of the cost of cardiovascular disease. Can J Cardiol 25, e195-202, doi:10.1016/s0828-282x(09)70098-4 (2009).
29 Gebreyes;, K. et al. The US$2.8 trillion opportunity: How better health for all can drive US economic growth, <https://www2.deloitte.com/us/en/insights/industry/health-care/health equity-economic-impact.html> (2024).
30 Dash, P. et al. How prioritizing health could help rebuild economies, <https://www.mckinsey.com/industries/healthcare/our-insights/how-prioritizing-health-could help-rebuild-economies> (2020).